Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prospective Study on Rehabilitation Patients With Pulmonary Hypertension and Other Pulmonary Diseases

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02002351
Recruitment Status : Completed
First Posted : December 5, 2013
Last Update Posted : March 30, 2016
Sponsor:
Collaborator:
Actelion
Information provided by (Responsible Party):
Paracelsus Harz Clinic Bad Suderode.

Brief Summary:
This monocentric registry should provide information on the extent how patients with pulmonary diseases such as pulmonary hypertension will benefit from rehabilitation treatment. The data may provide a basis for further prospective studies showing the treatment of patients with pulmonary diseases especially by physical activation.

Condition or disease
Pulmonary Diseases Rehabilitation

Layout table for study information
Study Type : Observational [Patient Registry]
Actual Enrollment : 450 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 12 Months
Study Start Date : December 2013
Actual Primary Completion Date : December 2015
Actual Study Completion Date : March 2016

Resource links provided by the National Library of Medicine


Group/Cohort
Pulmonary disease



Primary Outcome Measures :
  1. Data collection [ Time Frame: 12 Months ]
    Characterization of patients with pulmonary hypertension and other pulmonary diseases in a german rehabilitation clinic.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All rehabilitation patients with pulmonary diseases in the Paracelsus-Harz-Clinic Bad Suderode will be included, starting December 2013,ending Novermber 2014.
Criteria

Inclusion Criteria:

  • Pulmonary Disease

Exclusion Criteria:

  • Inability or refusal to give written informed consent

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02002351


Locations
Layout table for location information
Germany
Paracelsus Harz Clinic Bad Suderode
Quedlinburg, Saxony-Anhalt, Germany, 06485
Sponsors and Collaborators
Paracelsus Harz Clinic Bad Suderode.
Actelion
Additional Information:

Layout table for additonal information
Responsible Party: Paracelsus Harz Clinic Bad Suderode.
ClinicalTrials.gov Identifier: NCT02002351    
Other Study ID Numbers: ParacelsusHCBS 22/13
First Posted: December 5, 2013    Key Record Dates
Last Update Posted: March 30, 2016
Last Verified: January 2015
Additional relevant MeSH terms:
Layout table for MeSH terms
Lung Diseases
Respiratory Tract Diseases